ART - antiretroviral therapy
ICAP and PEPFAR Release Adaptable Training Package for Dolutegravir Transition
ICAP at Columbia University, in partnership with the President’s Emergency Plan for AIDS Relief (PEPFAR), through the USAID-funded OPTIMIZE Project, has developed a health care worker training package for countries transitioning to dolutegravir (DTG)-based regimens...
New HIV Data from Ethiopia Sparks Renewed Optimism
Results from an HIV survey of unprecedented scope, led by ICAP at Columbia University, spurred optimism throughout Ethiopia this week. On Monday, Ethiopia became the latest country to announce data from the fourteen-country Population-based HIV Impact Assessment...
ICAP’s “Test and Treat All” Resources Guide Countries Toward Controlling HIV Epidemics
Recognizing that antiretroviral therapy (ART) “keeps people living with HIV alive, healthier and reduces the risk of transmitting the virus to partners,” the World Health Organization in 2015 recommended that anyone infected with HIV should begin ART as soon after...
